Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial.
作者:
主题词
青少年(Adolescent);注意力缺陷障碍伴多动(Attention Deficit Disorder with Hyperactivity);中枢神经系统刺激剂(Central Nervous System Stimulants);儿童(Child);迟效制剂(Delayed-Action Preparations);剂量效应关系, 药物(Dose-Response Relationship, Drug);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);男(雄)性(Male);院校(Schools);治疗结果(Treatment Outcome)
DOI
10.1016/j.clinthera.2021.01.027
PMID
33750646
发布时间
2021-10-25
- 浏览2

Clinical therapeutics
684-700页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文